Christopher J. Coughlin

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christopher A. Koster (executed by attorney-in-fact)
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christopher J. Coughlin

Form 4 holding Director

CENTENE CORP

Security class
Common Stock
Shares / value
30,054
Estimated value
$983,967
Report date
30 Jun 2026
Price
$32.74
Ownership
By Grantor Retained Annuity Trust
Form 4 holding Director

CENTENE CORP

Security class
Common Stock Option (right to buy)
Shares / value
10,000
Estimated value
$386,700
Report date
31 Dec 2025
Price
$38.67
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Form 4 holding Director

Karuna Therapeutics, Inc.

Security class
Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
18 Mar 2024
Price
$92.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALEXION PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
21 Jul 2021
Price
$155.01
Ownership
Direct
Underlying class
Common Stock, par value $.0001 per share
Underlying amount

Insider Reports Filed by Christopher J. Coughlin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .